Safety review of tetanus toxoid, reduced diphtheria toxoid, acellular pertussis vaccines (Tdap) in adults aged≥ 65 years, Vaccine Adverse Event Reporting System …

P Haber, PL Moro, C Ng, GM Dores, S Perez-Vilar… - Vaccine, 2020 - Elsevier
… among elderly Tdap recipients [7]. In general, few studies have assessed the safety of Tdap
… time period subsequent to the initial ACIP recommendations for Tdap in this age group [8]. …

Tetanus, diphtheria and acellular pertussis (Tdap) vaccine for prevention of pertussis among adults aged 19 years and older in the United States: A cost-effectiveness …

BH Cho, AM Acosta, AJ Leidner, AE Faulkner… - Preventive medicine, 2020 - Elsevier
… For vaccination program costs, we used the cost of Tdap vaccine as well as the vaccine
In previous studies, only the incremental price of replacing Td vaccine with Tdap vaccine were …

[HTML][HTML] Use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines: updated recommendations of the Advisory Committee on Immunization …

FP Havers - MMWR. Morbidity and mortality weekly report, 2020 - cdc.gov
Tdap during each pregnancy (off-label use), and children aged 7–10 years who received
Tdap … However, given the reassuring safety profile and evidence of widespread use of Tdap in …

The burden of pertussis in older adults: what is the role of vaccination? A systematic literature review

W Kandeil, P Atanasov, D Avramioti, J Fu… - Expert review of …, 2019 - Taylor & Francis
… We identified 12 relevant publications on the immunogenicity and safety of pertussis
booster vaccines in older adults, based on studies conducted in Europe, Australia and North …

Diphtheria, Tetanus and Pertussis Vaccines

VM Vashishtha, UA Upadhyay - … on Vaccines and Immunization …, 2020 - books.google.com
vaccine for anyone older than age 64 years, and ACIP has not recommended off-label use
of Tdap … Estimating the effectiveness of tetanus-diphtheria-acellular pertussis vaccine (Tdap) …

Economic impact of implementing decennial tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccination in adults in the United States

FP Havers, BH Cho, JW Walker, S Hariri - Vaccine, 2020 - Elsevier
… Td or Tdap vaccination; [1] no safety concerns have been reported with this off-label use. In
… For those 65 years and older, direct costs were calculated using Centers for Medicare and …

Boosting teenagers with acellular pertussis vaccines containing recombinant or chemically inactivated pertussis toxin: a randomized clinical trial

G Blanchard Rohner, O Chatzis… - Clinical Infectious …, 2019 - academic.oup.com
… reduction of bacterial circulation in older age groups. … more rapid in tetanus-diphtheria-acellular
pertussis vaccine (Tdap)–… Thai adults indicated similar safety but significantly higher PT …

[PDF][PDF] Vaccines in adults

M Roses, PE Bonvehí - Medicina (Buenos Aires), 2019 - medicinabuenosaires.com
… that, by 2050, the group of 60 years and older will represent 21.1%. There are now vaccines
Safety of a tetanusdiphtheria-acellular pertussis vaccine when used off-label in an elderly

… after acellular versus whole-cell pertussis vaccines in infants born to mothers who received tetanus, diphtheria, and acellular pertussis vaccine during pregnancy: a …

N Wanlapakorn, K Maertens… - Clinical Infectious …, 2020 - academic.oup.com
… In summary, if countries using wP-containing vaccines for priming of infants are … Tdap
immunization, the blunting following wP vaccination should be taken into account. Vaccine-…

Emerging topics in vaccine therapeutics for adolescents and adults: an update for immunizing pharmacists

JP Fava, B Stewart, KM Dudzinski… - Journal of …, 2020 - journals.sagepub.com
… for immunizations allows for off-label vaccination with MenACWY in patients 56 years and
older. If … of MenB-FHbp with Tdap, HPV4, or MCV4 was safe and did not significantly affect the …